(21) first demonstrated the hypermethylation of the RASSF1A gene promoter in breast cancer, highlighting epigenetic silencing as a mechanism for oncogene inactivation, and paving the way for further studies on promoter methylation in other genes (21). This evidence concerns the gene RASSF1 and breast cancer.